CARSGEN-B(02171),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community - To The Moon

At the request of the exchanges, the U.S./Hong Kong stock quotes are displayed on a 15-minute delay, download the APP to view the real-time quotes for free.

Close

02171 CARSGEN-B

Market Closed 08-07 16:08:13

15.330

+0.450

+3.02%

High15.650	Low14.880	Vol3.04M
Open14.860	D1 Closing14.880	Amplitude5.17%
Mkt Cap9.11B	Tradable Cap9.11B	Total Shares594.00M
T/O46.63M	T/O Rate0.51%	Tradable Shares594.00M
P/B--	ROE--	EPS0.00
52wk High--	52wk Low--	P/E--
Dividend--	Div.Yield--	ROA--

Loading ...

Disclaimer: HKEx Information Services Limited, its holding companies and/or any subsidiaries of such holding companies endeavour to ensure the accuracy and reliability of the information provided, but do not guarantee its absolute accuracy and reliability and accept no liability (whether in tort or contract or otherwise) for any loss or damage arising from any inaccuracies or omissions.

{"stockData":{"symbol":"02171","market":"HK","secType":"STK","nameCN":"CARSGEN-B","latestPrice":15.33,"timestamp":1786090093003,"preClose":14.88,"halted":0,"volume":3037974,"delay":0,"changeRate":0.03024193548387092,"floatShares":594000000,"shares":594000000,"eps":-0.177264,"marketStatus":"Market Closed","change":0.45,"latestTime":"08-07 16:08:13","open":14.86,"high":15.65,"low":14.88,"amount":46627682,"amplitude":0.051747,"askPrice":15.39,"askSize":20000,"bidPrice":15.33,"bidSize":1000,"shortable":3,"etf":0,"ttmEps":-0.182,"tradingStatus":0,"nextMarketStatus":{"tag":"Open","tradingStatus":2,"beginTime":1786325400000},"marketStatusCode":7,"adr":0,"listingDate":1623945600000,"exchange":"SEHK","adjPreClose":14.88,"openAndCloseTimeList":[[1786066200000,1786075200000],[1786078800000,1786089600000]],"volumeRatio":1.1973,"lotSize":500,"spreadScale":0,"tradeCurrency":"HKD"},"requestUrl":"/m/hq/s/02171/wiki","defaultTab":"wiki","newsList":[{"id":"2657226618","title":"CARsgen Therapeutics Wins China IND Clearance for Lymphoma Cell Therapy","url":"https://stock-news.laohu8.com/highlight/detail?id=2657226618","media":"MT Newswires Live","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2657226618?lang=en_us&edition=fundamental","pubTime":"2026-08-07 15:38","pubTimestamp":1786088298,"startTime":"0","endTime":"0","summary":"CARsgen Therapeutics  said its investigational new drug application for CT1190B, an allogeneic CAR T-cell therapy targeting CD19/CD20, received clearance from China's National Medical Products Administration, according to a Friday Hong Kong bourse filing.The clearance allows the company to begin a clinical trial of CT1190B in patients with relapsed or refractory large B-cell lymphoma who have failed at least two prior lines of standard therapy.z","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK1574","BK4139","BK1161","IND","LENZ","BK4007","BK1585","BK4539","02171","BK1587"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1163799508","title":"CARSGEN-B (02171) Surges Over 4% as CT1190B Gets IND Nod for R/R LBCL Patients After Second-Line Failure","url":"https://stock-news.laohu8.com/highlight/detail?id=1163799508","media":"Stock News","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1163799508?lang=en_us&edition=fundamental","pubTime":"2026-08-07 10:52","pubTimestamp":1786071162,"startTime":"0","endTime":"0","summary":"CARSGEN-B (02171) extended its rally, climbing more than 4% in Monday's trading session. As of the latest update, the stock was up 4.03% to HK$15.48, with trading volume reaching HK$21.99 million.On...","market":"sg","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["VXUS","BK4588","BK1585","BK1161","BK1587","BK4585","KCAI","02171","BK1574"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1147606546","title":"CARSGEN-B Receives IND Clearance from Chinese Drug Regulator for Novel Cell Therapy Targeting Lymphoma","url":"https://stock-news.laohu8.com/highlight/detail?id=1147606546","media":"Stock News","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1147606546?lang=en_us&edition=fundamental","pubTime":"2026-08-07 08:12","pubTimestamp":1786061532,"startTime":"0","endTime":"0","summary":"CARSGEN-B (02171) has announced that its investigational cell therapy, CT1190B, has received clinical trial approval from China's National Medical Products Administration (NMPA).This \"off-the-shelf\"...","market":"sg","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02171","IND","BK1574","BK1585","BK1161","BK1587"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2657132664","title":"CARsgen Says NMPA Clears IND for Ct1190b in Relapsed/refractory Large B-Cell Lymphoma","url":"https://stock-news.laohu8.com/highlight/detail?id=2657132664","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2657132664?lang=en_us&edition=fundamental","pubTime":"2026-08-07 08:00","pubTimestamp":1786060851,"startTime":"0","endTime":"0","summary":"CARsgen says NMPA clears IND for CT1190B in relapsed/refractory large B-cell lymphomaCARsgen won NMPA IND clearance for CT1190B in relapsed or refractory large B-cell lymphoma patients who failed at l","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260807:nNDL1G2L5N:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02171","BK1574","BK1585","BK1587","BK1161"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2657666418","title":"CARsgen Therapeutics - Ct1190b Receives Ind Clearance from Nmpa for Relapsed/Refractory Large B-Cell Lymphoma","url":"https://stock-news.laohu8.com/highlight/detail?id=2657666418","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2657666418?lang=en_us&edition=fundamental","pubTime":"2026-08-07 08:00","pubTimestamp":1786060840,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260807:nFWN4432H3:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK1587","BK1161","02171","BK1574","BK1585"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1134654610","title":"CARsgen Schedules 18 Aug 2026 Board Meeting to Approve 1H 2026 Interim Results","url":"https://stock-news.laohu8.com/highlight/detail?id=1134654610","media":"Bulletin Express","labels":["SGX"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1134654610?lang=en_us&edition=fundamental","pubTime":"2026-08-06 17:46","pubTimestamp":1786009584,"startTime":"0","endTime":"0","summary":"CARsgen Therapeutics Holdings Limited announced that its board of directors will convene on 18 August 2026 to review and approve the Group’s interim results for the six months ended 30 June 2026, and...","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02171"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2657681531","title":"CARsgen Therapeutics Schedules Board Meeting to Review Interim Results","url":"https://stock-news.laohu8.com/highlight/detail?id=2657681531","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2657681531?lang=en_us&edition=fundamental","pubTime":"2026-08-06 17:31","pubTimestamp":1786008676,"startTime":"0","endTime":"0","summary":"CARsgen Therapeutics schedules board meeting to review interim resultsCARsgen Therapeutics will hold a board meeting on Aug. 18, 2026 to review the group’s interim results for the six months ended Jun","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260806:nNDL73lfnB:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02171","BK1161","BK1587","BK1585","BK1574"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2656958065","title":"CARsgen Therapeutics Receives China IND Clearance for Multiple Myeloma Therapy; Shares Up 3%","url":"https://stock-news.laohu8.com/highlight/detail?id=2656958065","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2656958065?lang=en_us&edition=fundamental","pubTime":"2026-08-04 14:30","pubTimestamp":1785825028,"startTime":"0","endTime":"0","summary":"CARsgen Therapeutics' (HKG:2171) CT0596 obtained investigational new drug clearance from China's National Medical Products Administration, according to a Monday Hong Kong bourse filing.Shares of the b","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK1585","BK1161","LENZ","BK4539","BK4007","BK4139","BK1587","IND","BK1574","02171"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2656586682","title":"Carsgen Therapeutics Says Ct0596 Receives IND Clearance from NMPA","url":"https://stock-news.laohu8.com/highlight/detail?id=2656586682","media":"Reuters","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2656586682?lang=en_us&edition=fundamental","pubTime":"2026-08-04 09:52","pubTimestamp":1785808348,"startTime":"0","endTime":"0","summary":"BRIEF-Carsgen Therapeutics Says CT0596 Receives IND Clearance From NMPAAug 4 (Reuters)-CARsgen Therapeutics Holdings Ltd2171.HK:CT0596 RECEIVES IND CLEARANCE FROM NMPA FOR RELAPSED/REFRACTORY MULTIPLE MYELOMAFurther company coverage:2171.HK","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260804:nFWN44012P:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1161","BK1585","02171","BK1574","BK1587"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1151736677","title":"China's Nod Granted to CARSGEN-B's BCMA-Targeting Universal CAR-T for Hard-to-Treat Myeloma","url":"https://stock-news.laohu8.com/highlight/detail?id=1151736677","media":"Stock News","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1151736677?lang=en_us&edition=fundamental","pubTime":"2026-08-04 08:14","pubTimestamp":1785802452,"startTime":"0","endTime":"0","summary":"CARSGEN-B (02171) has announced that its universal CAR-T cell product, CT0596, which targets BCMA, has received Investigational New Drug (IND) approval from China's National Medical Products...","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1574","BK1161","IND","BK1585","BK1587","02171"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1136831406","title":"CARsgen Secures NMPA IND Clearance for Allogeneic BCMA CAR-T Candidate CT0596 in Relapsed/Refractory Multiple Myeloma","url":"https://stock-news.laohu8.com/highlight/detail?id=1136831406","media":"Bulletin Express","labels":["productRelease","SGX"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1136831406?lang=en_us&edition=fundamental","pubTime":"2026-08-04 08:03","pubTimestamp":1785801835,"startTime":"0","endTime":"0","summary":"CARsgen Therapeutics Holdings Limited (CARsgen) announced that the National Medical Products Administration (NMPA) has granted Investigational New Drug (IND) clearance for CT0596, an allogeneic...","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease,SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02171"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2656588436","title":"CARsgen Says Ct0596 Wins NMPA IND Clearance for Relapsed/refractory Multiple Myeloma","url":"https://stock-news.laohu8.com/highlight/detail?id=2656588436","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2656588436?lang=en_us&edition=fundamental","pubTime":"2026-08-04 08:01","pubTimestamp":1785801704,"startTime":"0","endTime":"0","summary":"CARsgen says CT0596 wins NMPA IND clearance for relapsed/refractory multiple myelomaCARsgen won NMPA IND clearance for CT0596, an allogeneic BCMA-targeted CAR-T, in relapsed or refractory multiple mye","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260804:nNDL7mlDDx:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1574","BK1161","02171","BK1587","BK1585"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2656881035","title":"CARsgen Therapeutics - Ct0596 Receives Ind Clearance from Nmpa for Relapsed/Refractory Multiple Myeloma","url":"https://stock-news.laohu8.com/highlight/detail?id=2656881035","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2656881035?lang=en_us&edition=fundamental","pubTime":"2026-08-04 08:00","pubTimestamp":1785801657,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260804:nFWN44012P:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK1574","BK1587","02171","BK1161","BK1585"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2654062631","title":"CARsgen Therapeutics Holdings (SEHK:2171) Gains Clinical Momentum Following Satri Cel Trial Update But Looks Pricey","url":"https://stock-news.laohu8.com/highlight/detail?id=2654062631","media":"Simply Wall St.","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2654062631?lang=en_us&edition=fundamental","pubTime":"2026-07-27 02:18","pubTimestamp":1785089897,"startTime":"0","endTime":"0","summary":"CARsgen Therapeutics Holdings (SEHK:2171) drew fresh attention after reporting preliminary positive results from a Chinese investigator initiated trial of its Claudin18.2 CAR T therapy, satri cel, which has been accepted for poster presentation at ESMO 2026.\nSee our latest analysis for CARsgen Therapeutics Holdings.\nAt a share price of HK$14.77, CARsgen Therapeutics Holdings has recently combined a 12.32% 1 month share price return with a 38.92% decline over 3 months and a 38.97% fall in the...","market":"nz","thumbnail":"https://images.simplywall.st/asset/industry/6111000-choice1-main-header/1585186710114","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/6111000-choice1-main-header/1585186710114"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/hk/pharmaceuticals-biotech/hkg-2171/carsgen-therapeutics-holdings-shares/news/carsgen-therapeutics-holdings-sehk2171-gains-clinical-moment","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/hk/pharmaceuticals-biotech/hkg-2171/carsgen-therapeutics-holdings-shares/news/carsgen-therapeutics-holdings-sehk2171-gains-clinical-moment","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["BK1161","LENZ","BK1585","BK4539","BK1574","02171","BK4007","BK1587","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1116585143","title":"CARSGEN-B Allocates HK$4.98 Million for Share Buyback on July 17","url":"https://stock-news.laohu8.com/highlight/detail?id=1116585143","media":"Stock News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1116585143?lang=en_us&edition=fundamental","pubTime":"2026-07-17 22:40","pubTimestamp":1784299216,"startTime":"0","endTime":"0","summary":"On July 17, 2026, CARSGEN-B (HKEX: 02171) executed a share repurchase, utilizing approximately HK$4.98 million to acquire 322,500 of its own shares.","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1585","BK1574","02171","BK1587","BK1161"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2652528943","title":"Carsgen Files HKEX Next-day Disclosure Return, Issues 2,000 New Shares Via Option Exercise","url":"https://stock-news.laohu8.com/highlight/detail?id=2652528943","media":"Reuters","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2652528943?lang=en_us&edition=fundamental","pubTime":"2026-07-17 22:36","pubTimestamp":1784298996,"startTime":"0","endTime":"0","summary":"CARsgen files HKEX next-day disclosure return, issues 2,000 new shares via option exerciseCARsgen filed a next-day disclosure return on July 17, 2026 covering changes in share capital.Issued 2,000 new","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260717:nNDL7xwSLl:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1587","BK1161","02171","BK1574","BK1585"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1156845057","title":"Movement Alert｜CARsgen Therapeutics-B Falls 6.03% in Regular Trading, Biotech Sector Under Broad Selling Pressure","url":"https://stock-news.laohu8.com/highlight/detail?id=1156845057","media":"Market Focus","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1156845057?lang=en_us&edition=fundamental","pubTime":"2026-07-17 10:04","pubTimestamp":1784253884,"startTime":"0","endTime":"0","summary":"On July 17, CARsgen Therapeutics-B fell 6.03% in regular trading, trading at HK$15.98/share, with turnover of approximately HK$16.93 million. The decline came amid a broad sell-off across the...","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02171"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1189418681","title":"CARSGEN-B Shares Surge Over 7% in Session as CT041 Passes Initial Review for 2026 Commercial Health Insurance Innovation Drug Catalog","url":"https://stock-news.laohu8.com/highlight/detail?id=1189418681","media":"Deep News","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1189418681?lang=en_us&edition=fundamental","pubTime":"2026-07-16 11:50","pubTimestamp":1784173827,"startTime":"0","endTime":"0","summary":"Shares of CARSGEN-B (HKEX: 02171) rose more than 7% during the trading session. At the time of writing, the stock is up 5.32% to HK$16.83, with a trading turnover of HK$52.48 million. On July 16th,...","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["06978","159992","BK1585","IBBQ","02171","BK1161","BK1587","BK1574","MEDX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1143100649","title":"Movement Alert｜CARsgen Therapeutics-B Rises 5.51% in Regular Trading, Kelimei Post-Surgical Consolidation Therapy Positive Results Accepted for ESMO Poster Presentation","url":"https://stock-news.laohu8.com/highlight/detail?id=1143100649","media":"Market Focus","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1143100649?lang=en_us&edition=fundamental","pubTime":"2026-07-16 10:28","pubTimestamp":1784168890,"startTime":"0","endTime":"0","summary":"On July 16, CARsgen Therapeutics-B rose 5.51% in regular trading, trading at HK$16.89/share, with turnover of HK$29.95 million.On the news front, the company announced on July 15 that preliminary...","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02171"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1166244460","title":"Hong Kong Stocks Midday Update: Hang Seng Index Rises 1.46%, Innovation Pharma Soars","url":"https://stock-news.laohu8.com/highlight/detail?id=1166244460","media":"Stock News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1166244460?lang=en_us&edition=fundamental","pubTime":"2026-07-15 12:12","pubTimestamp":1784088731,"startTime":"0","endTime":"0","summary":"The Hong Kong market saw gains at midday, with the Hang Seng Index advancing 1.46%, adding 354 points to reach 24,695. The Hang Seng Tech Index also climbed, rising 1.39%. Trading volume for the...","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["03067","07200","03088","HHImain","03419","HSI","03115","BK1574","BK1587","HSIBNI","BK1161","MCHmain","09088","03037","03423","HSImain","07552","03033","07300","07500","09115","07226","09067","83115","02833","82800","02837","HTImain","02171","513600","03417","HSTECH","BK1585","03032","02800"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"websiteUrl":"http://www.carsgen.com","stockEarnings":[{"period":"1week","weight":0.1432},{"period":"1month","weight":0.0358},{"period":"3month","weight":-0.3415},{"period":"6month","weight":0.0849},{"period":"1year","weight":-0.2366},{"period":"ytd","weight":0.0323}],"compareEarnings":[{"period":"1week","weight":-0.0084},{"period":"1month","weight":0.0607},{"period":"3month","weight":-0.0275},{"period":"6month","weight":-0.0336},{"period":"1year","weight":0.0234},{"period":"ytd","weight":0.0015}],"compareStock":{"symbol":"HSI","name":"HSI"},"description":"CARsgen Therapeutics Holdings Ltd is an investment holding company primarily engaged in discovering, researching and developing cell therapies. The Company’s main business is engaged in developing chimeric antigen receptor T cell (CAR T) -cell therapies to address clinical needs including but not limited to hematologic malignancies solid tumors and autoimmune diseases. The Company’s main products include zevor-cel (zevorcabtagene autoleucel), satricabtagene autoleucel and allogeneic CAR T-cell products. The Company conducts its business in the domestic and overseas markets.","yearOnYearQuotes":[{"month":1,"riseRate":0.6,"avgChangeRate":-0.07858},{"month":2,"riseRate":0.6,"avgChangeRate":0.230493},{"month":3,"riseRate":0.2,"avgChangeRate":-0.058535},{"month":4,"riseRate":0.4,"avgChangeRate":-0.02351},{"month":5,"riseRate":0.6,"avgChangeRate":0.035849},{"month":6,"riseRate":0.4,"avgChangeRate":-0.015777},{"month":7,"riseRate":0.333333,"avgChangeRate":-0.022715},{"month":8,"riseRate":0.666667,"avgChangeRate":0.079027},{"month":9,"riseRate":0.4,"avgChangeRate":0.033481},{"month":10,"riseRate":0.6,"avgChangeRate":0.024843},{"month":11,"riseRate":0.6,"avgChangeRate":0.051023},{"month":12,"riseRate":0.4,"avgChangeRate":-0.058482}],"exchange":"SEHK","name":"CARSGEN-B","nameEN":"CARSGEN-B"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"isLaohu8Offline":false,"tenantId":"TBGLOBAL","deviceId":"web-server-community-laohu8-v3","version":"4.47.1","shortVersion":"4.47.1","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"CARSGEN-B(02171),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","description":"Find the latest CARSGEN-B(02171) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","keywords":"CARSGEN-B,02171,CARSGEN-B股票,CARSGEN-B股票老虎,CARSGEN-B股票老虎国际,CARSGEN-B行情,CARSGEN-B股票行情,CARSGEN-B股价,CARSGEN-B股市,CARSGEN-B股票价格,CARSGEN-B股票交易,CARSGEN-B股票购买,CARSGEN-B股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"CARSGEN-B(02171),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","og_description":"Find the latest CARSGEN-B(02171) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","og_image":"https://community-static.tradeup.com/news/9b6dafd60190235ae8e2c95f52c583a0"}}}